Cardiff Oncology Insider Trades

CRDF

Track insider trading activity from Cardiff Oncology executives and directors. See which insiders are buying and selling CRDF stock.

Trades Last 12 Months

CRDF Price

All Insider Trades for Cardiff Oncology

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Smeal Tod Chief Scientific Officer
Holding Value $1.79M 1,279,805 shares
Last Trade
Apr 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$489k 300,000 shares
$1.63
$1.40
Muntner Joshua B Chief Financial Officer
Holding Value $682k 487,150 shares
Last Trade
Apr 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$769k 486,650 shares
$1.58
$1.40
Mohindru Mani Chief Executive Officer
Holding Value $1.36M 968,766 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 600,000 shares
$1.62
$1.40
Lindsay Brigitte Ute Chief Accounting Officer
Holding Value $1.44M 1,025,334 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$320k 200,000 shares
$1.60
$1.40
Pace Gary W Director
Holding Value $1.88M 1,345,676 shares
Last Trade
Jul 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$711k 290,000 shares
$2.45
$1.40
Markin Rodney S Director
Holding Value $312k 222,865 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 40,565 shares
$3.16
$1.40
White Lale Director
Holding Value $222k 158,681 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 40,565 shares
$3.16
$1.40
Holding Value $236k 168,766 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 40,565 shares
$3.16
$1.40
Armitage James O Director
Holding Value $263k 187,539 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 40,565 shares
$3.16
$1.40
Sidhu Roger Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jun 16, 2025 Sale
$2.32M 600,000 shares
$3.86
$1.40
Levine James E. Chief Financial Officer
Holding Value $1.81M 1,295,117 shares
Last Trade
Mar 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 332,621 shares
$3.58
$1.40
Kabbinavar Fairooz Chief Medical Officer
Holding Value $1.09M 780,008 shares
Last Trade
Mar 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$537k 150,000 shares
$3.58
$1.40
Erlander Mark Chief Executive Officer
Holding Value $4.1M 2,925,098 shares
Last Trade
Mar 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.72M 758,400 shares
$3.58
$1.40
Kelemen Vicki Exec. VP And COO
Holding Value $978k 698,304 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$216k 125,520 shares
$1.72
$1.40
Holding Value $175k 125,317 shares
Last Trade
Jun 09, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$49.5k 22,000 shares
$2.25
$1.40
Ruffner Katherine L Chief Medical Officer
Holding Value $518k 370,016 shares
Last Trade
Mar 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 170,016 shares
$2.50
$1.40
Holding Value $669k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.38M 298,320 shares
$7.98
$1.40
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.74k 218 shares
$7.98
$1.40
Holding Value $64.4k 46,019 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 44,734 shares
$2.48
$1.40
Tennant Stanley Director
Holding Value $330k 236,061 shares
Last Trade
Jun 08, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$55.2k 10,000 shares
$5.52
$1.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up